(aripiprazole lauroxil) extended-release injectable suspension
The information contained in this learning resource contains a portion of the product information. For full details see the product information by each product owner. A full list can be found in the References tab.
Yes3
Yes3
There are two ways to initiate treatment with ARISTADA:
Option #1: One dose 675 mg IM ARISTADA INITIO + one dose 30 mg PO aripiprazole in conjunction with the first ARISTADA injection (441 mg, 662 mg, or 882 mg Q1M, 882 mg Q6W, or 1064 mg Q2M). The first ARISTADA injection may be administered on the same day as ARISTADA INITIO or up to 10 days thereafter.
Option #2: PO aripiprazole x 21 days in conjunction with the first ARISTADA injection (441 mg, 662 mg, or 882 mg Q1M, 882 mg Q6W, or 1064 mg Q2M).
When a dose of ARISTADA is missed, administer the next injection of ARISTADA as soon as possible. Depending on the time elapsed since the last ARISTADA injection, supplement the next ARISTADA injection as recommended.
No3
Aqueous suspension3
Tap the syringe containing ARISTADA at least 10 times and then shake vigorously for a minimum of 30 seconds.3
If not administered within 15 mins of preparation, then shake again for 30 seconds.3
43
------------------------------------------
10 mg QD PO aripiprazole = 441 mg Q1M ARISTADA
15 mg QD PO aripiprazole = 662 mg Q1M, 882 mg Q6WK, or 1064 mg Q2M ARISTADA
≥20 mg QD PO aripiprazole = 882 mg Q1M ARISTADA3
1.6 mL (441 mg dose) - 3.9 mL (1064 mg dose):3
1, 1.5, 23
20, 213
IM (deltoid or gluteal)3
21 gauge, 1-inch (441 mg dose)
20 gauge, 1.5-inch (441 mg dose)3
20 gauge, 1.5 inch (441 mg, 662 mg, 882 mg, or 1064 mg dose)
20 gauge, 2-inch (441 mg, 662 mg, 882 mg, or 1064 mg dose)3
n/a
Aqueous suspension3
Single-dose, prefilled syringe kit
1 single-dose, prefilled syringe containing ARISTADA aqueous suspension
+
2 or 3 safety needles to choose from for drug administration (21G/1-inch [441 mg kit only], 20G/2-inch [all kits], and 20G/1.5-inch [all kits])3
No3
Store prefilled syringe kit at room temperature (68°F to 77°F; 20°C to 25°C).3
Excursions permitted between 59°F and 86°F (15°C and 30°C).3
Not stated in PI
Not stated in PI
Room Temperature3
Tap the syringe containing ARISTADA at least 10 times and then shake vigorously for a minimum of 30 seconds.3
If not administered within 15 mins of preparation, then shake again for 30 seconds.3
By clicking the button below you agree to the following:
I am a US Health Care Professional.
I understand that S.C.O.P.E. is for educational purposes only and not to be used for the treatment or diagnosis of schizophrenia, nor is it a substitute for clinical judgment or guidelines.